>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
STAT3及其抑制剂在膀胱癌中的研究进展
作者:吴朝  董自强 
单位:三峡大学第一临床医学院, 湖北 宜昌 443003
关键词:膀胱癌 信号转导与转录激活因子3 抑制剂 文献综述 
分类号:R694
出版年·卷·期(页码):2015·34·第二期(313-316)
摘要:

信号转导与转录激活因子(STATs)是一类调节细胞信号转导和转录的蛋白质家族,它们作为信号转导分子在细胞因子和生长因子的作用下调节正常细胞的生长.STATs的异常激活,特别是STAT3的激活在人类的众多恶性肿瘤中都有表达.膀胱癌是人类泌尿系最常见的恶性肿瘤,STAT3在膀胱癌的发生、发展、侵袭、转移、耐药等方面都有重要作用,阻断STAT3信号通路可以抑制肿瘤细胞的生长和诱导凋亡.近年来针对STAT3抑制剂的研究逐渐成为热点也为膀胱癌的治疗提供了一个新的靶点,在本文中作者就此作一综述.

参考文献:

[1] HO P L, LAY E J,JIAN W,et al.STAT3 activation in urothelial stem cells lead to direct progression to invasive bladder cancer[J].Cancer Res,2012,72(13):3135-3142.
[2] SUN Y,CHENG M K,GRIFFITHS T R,et al.Inhibition of STAT signalling in bladder cancer by diindolylmethane-relevance to cell adhesion,migration and proliferation[J].Curr Cancer Drug Targets,2013,13(1):57-68.
[3] 严尔福,徐莲,刘文娟,等.新型抗癌药物分子靶标STAT3的研究进展[J].现代生物医学发展,2014,14(7):1388-1391.
[4] BEDNAREK L,SYPNIEWSKI D,GAWLIK N,et al.The efficiency of silencing expression of the gene coding STAT3 transcriptional factor and susceptibility of bladder cancer cells to apoptosis[J].Contemp Oncol(Pozn),2012,16(4):316-321.
[5] 杨立新,张海峰,白淑芬.P53、Ki-67基因表达与膀胱癌相关性的回顾性研究[J].现代医学,2010,38(1):32-35.
[6] SUN J,YU M,LU Y,et al.Carciongenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation[J].Cancer Lett,2014,346(2):257-263.
[7] 李建,周怀君.P13K/Akt信号通路在肿瘤研究中的进展[J].东南大学学报:医学版,2014,33(3):392-395.
[8] AZIZ M H,HAFEEZ B B,SAND J M,et al.Protein kinase C mediates Stat3Ser727 phosphoorylation,Stat3-regulated gene expression and cell invasion in various human cancer cell lines via integration with MAPK[J].Oncogene,2010,29(21):3100-3109.
[9] WANG L,YI T,KORTYLEWSKI M,et al.IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J].J Exp Med,2009,206(7):1457-1464.
[10] ZHOU H,HUANG H Y,SHAPIRO E,et al.Urothelial tumor initiation requires deregulation of multiple signaling pathways:implications in target-based therapies[J].Carcinogenesis,2012,33(4):770-780.
[11] LI Z,LI X,WU S,et al.Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway[J].Cancer Sci,2014,105(8):951-955.
[12] SHEN H B,GU Z Q,JIAN K,et al.CXCR4-mediated STAT3 activation is essential for CXCL12-induced cell invasion in bladder cancer[J].Tumour Biol,2013,34(3):1839-1845.
[13] YING H,DA L,YU-XIU S,et al.TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells[J].Inflammation,2013,36(5):1064-1074.
[14] ZHANG B,LU Z,HOU Y,et al.The effects of STAT3 and survivin silencing on the growth of human bladder carcinoma cells[J].Tumour Biol,2014,35(6):5401-5407.
[15] SEN M,JOYCE S,PANAHANDEH M,et al.Targeting STAT3 abrogates EGFR inhibitor resistance in cancer[J].Clin Cancer Res,2012,18(18):4986-4996.
[16] CHEN R J,HO Y S,GUO H R,et al.Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells[J].Toxicol Sci,2008,104(2):283-293.
[17] CHEN R J,HO Y S,GUO H R,et al.Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and Beta-adrenoceptors in human bladder cancer cells[J].Toxicoi Sci,2010,115(1):118-130.
[18] 袁小鹏,曾楚楚,邢丽华,等.STAT3抑制剂WP1066对乏氧人脑胶质瘤细胞U251放射敏感性的影响[J].辐射研究与辐射工艺学报,2014,32(1):1-6.
[19] HUANG W W,YANG J S,LIN M W,et al.Cucurbitacin E induces G2/M phase arrest through STAT3/p53/p21 signaling provokes apoptosis via Fas/CD95 and mitochondria-dependent pathways in human bladder cancer T24 cells[J].Evid Based Complement Alternat Med,2012,2012:952762.
[20] WANG J,CHEN S,XU S,et al.In vivo induction of apoptosis by fucoxanthin,a marine carotenoid,associated with down-regulating STAT3/EGFR signaling in sarcoma 180(S180)xenografts-bearing mice[J].Mar Drugs,2012,10(9):2055-2068.
[21] 张大永,吴家强,吴晓明.STAT3抑制剂及其抗肿瘤活性研究进展[J].药学进展,36(7):289-299.
[22] 潘丽,张宁,牛国君,等.以STAT3为靶标的抗肿瘤药物高通量筛选模型的建立和应用[J].生物技术通报,2014,12(4):187-192.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414243 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364